Plasmacytoid dendritic cells prime IFN-γ-secreting melanoma-specific CD8 lymphocytes and are found in primary melanoma lesions

被引:157
作者
Salio, M [1 ]
Cella, M
Vermi, W
Facchetti, F
Palmowski, MJ
Smith, CL
Shepherd, D
Colonna, M
Cerundolo, V
机构
[1] John Radcliffe Hosp, Weatherall Inst Mol Med, Tumor Immunol Unit, Oxford OX3 9DS, England
[2] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA
[3] Univ Brescia, Ist Anat Patol, Brescia, Italy
关键词
plasmacytoid dendritic cell; priming; Melan-A; tetramer; tumor immunity;
D O I
10.1002/eji.200323676
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Plasmacytoid dendritic cells (PDC) are a small population of leukocytes specialized in the production of type I IFN. It has been shown that PDC have a potent T cell stimulatory capacity in allogeneic mixed lymphocyte reaction, However, their role in initiating primary immune responses remains elusive. We report that blood PDC efficiently prime naive CD8(+) lymphocytes specific for the melan-A(26-35) epitope to become IFN-gamma producing cells in vitro. In addition, we found that CD40L-stimulated PDC induce expression on primed melan-A-specific T cells of cutaneous lymphocyte antigen and L-selectin (CD62L), homing receptors that allow the migration of effector cells to the inflamed skin. Finally, we show that PDC can be found in the peri-tumoral area of most primary cutaneous melanomas in vivo and that type I IFN-containing supernatants derived from PDC increase melanoma cell surface expression of CD95 and MHC class I and class II molecules in vitro. Our results suggest a new immunomodulatory role for tissue infiltrating PDC, which may prime tumor-specific T cell responses and affect tumor growth via soluble factors.
引用
收藏
页码:1052 / 1062
页数:11
相关论文
共 52 条
  • [1] Immature dendritic cells phagocytose apoptotic cells via αvβ5 and CD36, and cross-present antigens to cytotoxic T lymphocytes
    Albert, ML
    Pearce, SFA
    Francisco, LM
    Sauter, B
    Roy, P
    Silverstein, RL
    Bhardwaj, N
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (07) : 1359 - 1368
  • [2] The chemokine receptor switch paradigm and dendritic cell migration: its significance in tumor tissues
    Allavena, P
    Sica, A
    Vecchi, A
    Locati, M
    Sozzani, S
    Mantovani, A
    [J]. IMMUNOLOGICAL REVIEWS, 2000, 177 : 141 - 149
  • [3] Dendritic cells and the control of immunity
    Banchereau, J
    Steinman, RM
    [J]. NATURE, 1998, 392 (6673) : 245 - 252
  • [4] Belardelli F, 1998, CANCER RES, V58, P5795
  • [5] Cytokines as a link between innate and adaptive antitumor immunity
    Belardelli, F
    Ferrantini, M
    [J]. TRENDS IN IMMUNOLOGY, 2002, 23 (04) : 201 - 208
  • [6] In breast carcinoma tissue, immature dendritic cells reside within the tumor, whereas mature dendritic cells are located in peritumoral areas
    Bell, D
    Chomarat, P
    Broyles, D
    Netto, G
    Harb, GM
    Lebecque, S
    Valladeau, J
    Davoust, J
    Palucka, KA
    Banchereau, J
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (10) : 1417 - 1425
  • [7] THE CUTANEOUS LYMPHOCYTE ANTIGEN IS A SKIN LYMPHOCYTE HOMING RECEPTOR FOR THE VASCULAR LECTIN ENDOTHELIAL CELL-LEUKOCYTE ADHESION MOLECULE-1
    BERG, EL
    YOSHINO, T
    ROTT, LS
    ROBINSON, MK
    WARNOCK, RA
    KISHIMOTO, TK
    PICKER, LJ
    BUTCHER, EC
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 174 (06) : 1461 - 1466
  • [8] Frequent downregulation of Fas (CD95) expression and function in melanoma
    Bullani, RR
    Wehrli, P
    Viard-Leveugle, I
    Rimoldi, D
    Cerottini, JC
    Saurat, JH
    Tschopp, J
    French, LE
    [J]. MELANOMA RESEARCH, 2002, 12 (03) : 263 - 270
  • [9] Plasmacytoid dendritic cells activated by influenza virus and CD40L drive a potent THI polarization
    Cella, M
    Facchetti, F
    Lanzavecchia, A
    Colonna, M
    [J]. NATURE IMMUNOLOGY, 2000, 1 (04) : 305 - 310
  • [10] Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation
    Cella, M
    Scheidegger, D
    PalmerLehmann, K
    Lane, P
    Lanzavecchia, A
    Alber, G
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (02) : 747 - 752